Cargando…
Inferences for the Lead Time in Breast Cancer Screening Trials under a Stable Disease Model
We estimated the effects on the lead time for women participating in a long-term breast cancer screening program when the screening sensitivities and disease progression are independent of age. The lead time, or time by which a diagnosis is advanced by screening, is one of the major concerns of any...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757407/ https://www.ncbi.nlm.nih.gov/pubmed/24212799 http://dx.doi.org/10.3390/cancers3022131 |